Загрузка...
Towards the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma
OBJECTIVES: Early detection of Pancreatic Ductal Adenocarcinoma (PDAC) represents the most significant step towards the treatment of this aggressive lethal disease. Previously, we engineered a pre-clinical Thy1-targeted microbubble (MB(Thy1)) contrast agent that specifically recognizes Thy1 antigen...
Сохранить в:
| Опубликовано в: : | Invest Radiol |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541735/ https://ncbi.nlm.nih.gov/pubmed/32569010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLI.0000000000000697 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|